Injective vs THORChain — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while THORChain trades at Rp7,593 (market cap Rp2,56T, Rp68,48M 24h volume). The key difference: Injective is far larger — about 3.6× THORChain's market cap, and THORChain's supply is capped (338,2M / 354,2M RUNE (96%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and THORChain for 47 Days on average.
| INJ | RUNE | |
|---|---|---|
Market Cap | Rp9,18T | Rp2,56T |
Volume (24h) | Rp1,72T | Rp68,48M |
Circulating Supply | 100M INJ | 338,2M / 354,2M RUNE (96%) |
Typical Hold Time | 36 Days | 47 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
THORChain (RUNE) is trading at Rp7,539 with a market cap of Rp2.56T, showing a bullish technical signal driven by moving averages, though oscillators are neutral. The asset has strong support at Rp7,383 and resistance at Rp7,711. With 96% of its max supply in circulation and an average hold time of 47 days, the token demonstrates steady network participation. No major protocol upgrades or ecosystem news were reported recently, keeping fundamental developments quiet.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and regulatory uncertainty. Key opportunities lie in potential breakout above resistance, while major risks involve overbought RSI conditions and broader crypto market sentiment shifts. Investors should monitor trading volume and on-chain activity for confirmation of trend sustainability.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →THORCHain is a decentralized liquidity protocol that allows users to easily exchange cryptocurrency assets across a range of networks without losing full custody of their assets in the process. With THORChain, users can simply swap one asset for another in a permissionless setting, without needing to rely on order books to source liquidity. The native utility token of the THORChain platform is RUNE.
Read more on RUNE →